Applied Therapeutics, Inc. (NASDAQ:APLT) Receives $6.10 Consensus Price Target from Analysts
Shares of Applied Therapeutics, Inc. (NASDAQ:APLT – Get Free Report) have received an average recommendation of “Moderate Buy” from the six analysts that are covering the company, Marketbeat Ratings reports. Three analysts have rated the stock with a hold recommendation and three have given a buy recommendation to the company. The average 1-year price objective […]
Shares of Applied Therapeutics, Inc. (NASDAQ:APLT – Get Free Report) have received an average recommendation of “Moderate Buy” from the six analysts that are covering the company, Marketbeat Ratings reports. Three analysts have rated the stock with a hold recommendation and three have given a buy recommendation to the company. The average 1-year price objective […]
